West Pharmaceutical Services

S&P 500 Large-Cap Stocks Blue Chip Stocks Healthcare Stocks Best Dividend Stocks

$248.95

+17.33 (+7.48%)

As of Feb 8, 3:10 PM ET ·

Income Statement

	FY 2026	FY 2025	FY 2025	FY 2024	FY 2023
Revenue	2.70B	2.68B	18.68B	18.07B	16.48B
Net Income	459.53M	410.62M	1.11B	1.16B	1.11B
EPS	—	—	—	—	—
Profit Margin	17.0%	16.2%	6.0%	6.4%	6.7%
Rev Growth	+0.7%	+0.7%	-0.8%	+19.9%	-3.7%

Balance Sheet

	FY 2026	FY 2025	FY 2025	FY 2024	FY 2023
Total Debt	609.51M	609.51M	7.28B	6.90B	6.72B
Total Equity	7.95B	7.95B	9.56B	10.56B	10.04B
D/E Ratio	0.08	0.08	0.76	0.65	0.67

Cash Flow

	FY 2026	FY 2025	FY 2025	FY 2024	FY 2023
EBITDA	681.69M	642.97M	1.84B	1.64B	1.42B
Free Cash Flow	—	—	1.08B	1.22B	695.16M